Mint Tower Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Mint Tower Capital Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-56,790	Closed	-$1.37M	–	346
2023 Q1	$1.37M	Buy	+56,790	New	+$713K	0.14%	94

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Mint Tower Capital Management's PRVB Position: Q2 2023 in Review

Mint Tower Capital Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 56,790 shares — an estimated $1.37M sold.

Mint Tower Capital Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $1.37M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Mint Tower Capital Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Mint Tower Capital Management sold 56,790 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.37M.
Mint Tower Capital Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Mint Tower Capital Management's Provention Bio, Inc. Common Stock position peaked at $1.37M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Mint Tower Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.